NewsUSAW
U.S. Wrestling athlete Ben Provisor accepts sanction for Anti-Doping Rule Violation
by USADA
USADA announced November 15 that Ben Provisor, of Des Moines, Iowa, an athlete in the sport of wrestling, has accepted a 16-month suspension for an anti-doping rule violation.
Provisor, 32, tested positive for amphetamine as the result of an in-competition urine sample he provided at the Final X wrestling event on June 3, 2022. Amphetamine is a Non-Specified substance in the class of Stimulants and is prohibited in-competition under the USADA Protocol for Olympic and Paralympic Movement Testing, the United States Olympic and Paralympic Committee National Anti-Doping Policy, and the United World Wrestling Anti-Doping Rules, all of which have adopted the World Anti-Doping Code and the World Anti-Doping Agency Prohibited List.
After a thorough review of the case, including the examination of medical records provided by the athlete, USADA determined that Provisor’s positive test was caused by a medication, which he was using in a therapeutic dose and had previously been prescribed by a physician. Provisor, however, lacked a current prescription and a valid Therapeutic Use Exemption (TUE) at the time his urine sample was collected. Provisor has since obtained a prospective TUE through the established process under the International Standard for TUEs authorizing therapeutic use of this medication in sport.
Provisor’s 16-month period of ineligibility began on July 11, 2022, the date his provisional suspension was imposed. In addition, Provisor has been disqualified from all competitive results obtained on and subsequent to June 3, 2022, the date his positive sample was collected, including forfeiture of any medals, points and prizes.
In an effort to aid athletes, as well as support team members such as parents and coaches, in understanding the rules applicable to them, USADA provides comprehensive instruction on its website on the testing process and prohibited substances, how to file and update athlete Whereabouts, how to obtain permission to use a necessary medication, and the risks and dangers of taking supplements, as well as performance-enhancing and recreational drugs.
In addition, USADA manages a drug reference hotline, Global Drug Reference Online (www.GlobalDRO.com), conducts educational sessions with National Governing Bodies and their athletes, and distributes a multitude of educational materials, such as a supplement guide, a nutrition guide, a clean sport handbook , and periodic alerts and advisories.
USADA makes available a number of ways to report the abuse of performance-enhancing drugs in sport in an effort to protect clean athletes and promote clean competition. Any tip can be reported using the USADA Play Clean Tip Center, by text at 87232 (“USADA”), by email at playclean@USADA.org, by phone at 1-877-Play Clean (1-877-752-9253) or by mail.
USADA is responsible for the testing and results management process for athletes in the U.S. Olympic and Paralympic Movement and is equally dedicated to preserving the integrity of sport through research initiatives and educational programs.
Provisor, 32, tested positive for amphetamine as the result of an in-competition urine sample he provided at the Final X wrestling event on June 3, 2022. Amphetamine is a Non-Specified substance in the class of Stimulants and is prohibited in-competition under the USADA Protocol for Olympic and Paralympic Movement Testing, the United States Olympic and Paralympic Committee National Anti-Doping Policy, and the United World Wrestling Anti-Doping Rules, all of which have adopted the World Anti-Doping Code and the World Anti-Doping Agency Prohibited List.
After a thorough review of the case, including the examination of medical records provided by the athlete, USADA determined that Provisor’s positive test was caused by a medication, which he was using in a therapeutic dose and had previously been prescribed by a physician. Provisor, however, lacked a current prescription and a valid Therapeutic Use Exemption (TUE) at the time his urine sample was collected. Provisor has since obtained a prospective TUE through the established process under the International Standard for TUEs authorizing therapeutic use of this medication in sport.
Provisor’s 16-month period of ineligibility began on July 11, 2022, the date his provisional suspension was imposed. In addition, Provisor has been disqualified from all competitive results obtained on and subsequent to June 3, 2022, the date his positive sample was collected, including forfeiture of any medals, points and prizes.
In an effort to aid athletes, as well as support team members such as parents and coaches, in understanding the rules applicable to them, USADA provides comprehensive instruction on its website on the testing process and prohibited substances, how to file and update athlete Whereabouts, how to obtain permission to use a necessary medication, and the risks and dangers of taking supplements, as well as performance-enhancing and recreational drugs.
In addition, USADA manages a drug reference hotline, Global Drug Reference Online (www.GlobalDRO.com), conducts educational sessions with National Governing Bodies and their athletes, and distributes a multitude of educational materials, such as a supplement guide, a nutrition guide, a clean sport handbook , and periodic alerts and advisories.
USADA makes available a number of ways to report the abuse of performance-enhancing drugs in sport in an effort to protect clean athletes and promote clean competition. Any tip can be reported using the USADA Play Clean Tip Center, by text at 87232 (“USADA”), by email at playclean@USADA.org, by phone at 1-877-Play Clean (1-877-752-9253) or by mail.
USADA is responsible for the testing and results management process for athletes in the U.S. Olympic and Paralympic Movement and is equally dedicated to preserving the integrity of sport through research initiatives and educational programs.